Integrated Metabolomic and Transcriptomic Profiling Reveals Novel Activation-Induced Metabolic Networks in Human T cells

S. Hiemer, S. Jatav, J. Jussif, J. Alley, S. Lathwal, M. Piotrowski, J. Janiszewski, R. Kibbey, T. Alves, D. Dumlao, A. Jha, H. Bandukwala

Preprint posted on 15 May 2019

Feeding immunity: TCR stimulation leads to metabolic rewiring in human T cells to promote glucose and amino acid metabolism

Selected by Jonny Coates

Context and background

The primary function of effector CD4+ T cells, also known as helper T cells (TH), is to help activate other cells of the immune response. There are two main types of TH cells, T­1 and TH2 cells. TH1 cells activate the cellular immune response, usually against bacteria. The key cells that affect this response are CD8+ cytotoxic T cells, B cells and macrophages. TH1 T cells can activate these other immune cells through the secretion of pro-inflammatory cytokines such as TNF-α and IFN-γ. Alternatively, TH2 cells initiate a humoral immune response, characterised by antibody-producing B cells, eosinophils and mast cells. This is achieved by the release of interleukins such as IL-10 and IL-4 (CD4 T cells are reviewed in (1)).

In recent years, immunometabolism – that is metabolism within immune cells – has become a hot topic in immunology. Often, when immunologist talk about metabolism they are referring to glucose metabolism. In the context of T cells, upon activation T cells switch to a glycolytic metabolism (excellently reviewed in (2)). What makes this preprint by Hiemer et al especially interesting is the investigation into additional metabolites such as glutamine and the revelation of a much broader metabolic reprogramming than previously appreciated.

This preprint investigated the contribution of glucose and glutamine in promoting pro-inflammatory functions of effector T cells.


Key findings

  1. TCR stimulation leads to rapid reprogramming of metabolic pathways and nucleotide synthesis

The authors profiled the kinetics of T cell transcriptional and metabolomics changes at 2, 6 and 24 hours following TCR-stimulation. Among the differentially expressed genes, the authors found 4 distinct patterns:

  • Decreased expression
  • Transiently increased expression
  • Stably increased expression
  • Decreased expression at early time points and then subsequently increased

The authors confirmed that TCR signalling is required for the activation of metabolic pathways by deleting Zap70 with CRISPR (Zap70 is a key kinase involved in early TCR signalling) which reduced metabolic gene expression.  Surprisingly, this reduction occurred to a greater extent than CRISPR-mediated deletion of mTOR (mTOR is a major sensor of metabolism and can promote/repress expression of a large range of genes).

  1. Metabolic pathways synergistically promote nucleotide synthesis and TCA anaplerosis

Different metabolites were shown to be used for anaplerotic filling of TCA intermediates, for example enzymes involved in glutamine utilisation were upregulated, such as those involved in glutamine to glutamate and glutamate to α-ketoglutamate conversion. This is important as it suggests that there may be some degree of compensation between the pathways.

  1. The strength of TCR-stimulation differentially regulates metabolic reprogramming

The authors show that different strengths of TCR stimulation resulted in different metabolic reprogramming. Interestingly, although some different pathways were activated, the cells achieved the same endpoint.

  1. Cyclosporine treatment reduces the expression of genes involved in metabolism

Cyclosporine inhibits the NFAT (nuclear factor of activated T cells) transcription factor and can thereby reduce cytokines such as IL-2 (3). The paper illustrates that cyclosporine treatment also reduces the expression levels of metabolic enzymes, both in pathways activated following TCR-stimulation and in the steady state. This suggests that cyclosporine may be involved in maintaining metabolic homeostasis, supporting other recent literature demonstrating similar results (4,5).


Importance of paper & why I chose it

This paper paints a highly complex picture of T cell metabolism. Whilst the paper aligns well with my research interests, I chose this paper due to the approach that the authors used. The authors made excellent use of complementary techniques to thoroughly investigate their specific question. I think this is a good example of the power of combining –omics and systems biology approaches.


Open questions

  1. Perhaps the biggest open question relates to precisely how the altered metabolism is controlling T cell effector functions at the molecular level. For example, what is the contribution of the other metabolic pathways that were differentially regulated by TCR-stimulation? As it was not the purpose of the study, the authors do not directly manipulate individual metabolic pathways to assess the effect this may have on T cell effector functions. However, it’d be interesting to know what, if any, effects the authors believe this may have.
  2. Although standard culture treatments are used to activate the CD4+ T cells, it would be useful to see flow cytometry analysis of these populations, especially following the various treatments or CRISPR knockdowns. For example, are the cells all effector cells or is there a population of memory cells present?
  3. The authors show a reduction in IFN-γ, TNF-α and IL-2 but this evidence would perhaps be strengthened by assaying a wider range of T cell effector molecules in addition to demonstrating that negative regulators/suppressive cytokines (such as IL-10) are decreased.
  4. The authors show that the strength of TCR-stimulation can differentially regulate metabolic reprogramming.
    1. What do they think the impact of this finding is in vivo?
    2. What impact does this finding have on in vitro Should we take greater care with how we interpret TCR-stimulation experiments? Did the authors look at different affinity peptides?
    3. Do they think that this metabolic reprogramming is directly affecting the pro-inflammatory phenotype/response or is this a result of different signalling pathways?



  1. Wan YY, Flavell RA. How Diverse—CD4 Effector T Cells and their Functions. J Mol Cell Biol. 2009 Oct;1(1):20–36.
  2. O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65.
  3. Chow C-W, Rincón M, Davis RJ. Requirement for Transcription Factor NFAT in Interleukin-2 Expression. Mol Cell Biol. 1999 Mar;19(3):2300–7.
  4. Vaeth M, Feske S. NFAT control of immune function: New Frontiers for an Abiding Trooper. F1000Research [Internet]. 2018 Mar 2 [cited 2019 Jun 5];7. Available from:
  5. Klein-Hessling S, Muhammad K, Klein M, Pusch T, Rudolf R, Flöter J, et al. NFATc1 controls the cytotoxicity of CD8+ T cells. Nat Commun. 2017 11;8(1):511.



Posted on: 21 June 2019


Read preprint (4 votes)

Have your say

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up to customise the site to your preferences and to receive alerts

Register here

Also in the cell biology category:

Alumni picks – preLights 5th Birthday

This preList contains preprints that were picked and highlighted by preLights Alumni - an initiative that was set up to mark preLights 5th birthday. More entries will follow throughout February and March 2023.


List by Sergio Menchero et al.

CellBio 2022 – An ASCB/EMBO Meeting

This preLists features preprints that were discussed and presented during the CellBio 2022 meeting in Washington, DC in December 2022.


List by Nadja Hümpfer et al.


The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!


List by Osvaldo Contreras

EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)

A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.


List by Alex Eve

FENS 2020

A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020


List by Ana Dorrego-Rivas

Planar Cell Polarity – PCP

This preList contains preprints about the latest findings on Planar Cell Polarity (PCP) in various model organisms at the molecular, cellular and tissue levels.


List by Ana Dorrego-Rivas

BioMalPar XVI: Biology and Pathology of the Malaria Parasite

[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria


List by Dey Lab, Samantha Seah


Cell Polarity

Recent research from the field of cell polarity is summarized in this list of preprints. It comprises of studies focusing on various forms of cell polarity ranging from epithelial polarity, planar cell polarity to front-to-rear polarity.


List by Yamini Ravichandran

TAGC 2020

Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20


List by Maiko Kitaoka et al.

3D Gastruloids

A curated list of preprints related to Gastruloids (in vitro models of early development obtained by 3D aggregation of embryonic cells). Updated until July 2021.


List by Paul Gerald L. Sanchez and Stefano Vianello

ECFG15 – Fungal biology

Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome


List by Hiral Shah

ASCB EMBO Annual Meeting 2019

A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)


List by Madhuja Samaddar et al.

EMBL Seeing is Believing – Imaging the Molecular Processes of Life

Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019


List by Dey Lab


Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.


List by Sandra Malmgren Hill

Lung Disease and Regeneration

This preprint list compiles highlights from the field of lung biology.


List by Rob Hynds

Cellular metabolism

A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.


List by Pablo Ranea Robles

BSCB/BSDB Annual Meeting 2019

Preprints presented at the BSCB/BSDB Annual Meeting 2019


List by Dey Lab


This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.


List by Sandra Franco Iborra

Biophysical Society Annual Meeting 2019

Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA


List by Joseph Jose Thottacherry

ASCB/EMBO Annual Meeting 2018

This list relates to preprints that were discussed at the recent ASCB conference.


List by Dey Lab, Amanda Haage